StratDeckEarly access
Oxford Biomedica
OXB.LHealthcare · Biotechnology · UK509.00GBp-1.55%
StratDeckOxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
Price · Past year
Loading chart…
Checks
- Fail: Price trending down The figures
- Pass: Sales growing faster than its peers The figures
- Fail: Not making a profit The figures
- Pass: Analysts rate it a buy The figures
- Not known: Valuation not available
- Not known: Last quarter's profit forecast not available
Share
Keep researching
Where next from OXB.L
Other stocks you may like
Fundamentals
Yahoo FinanceShowHide
Market cap821M
P/E—
Forward P/E-69.6×
Price / book10.60
Revenue YoY+9.00%
Net margin-23.2%
Return on equity-89.7%
Beta0.92
52-week range420.00–962.0016/100
Worst fall in a year-53.6%
ADV (USD)3.28M
10d avg volume322K
What's happening?
OXB.L is beating Healthcare this month The figures
- 1D
- -1.55%
- 7D
- -2.30%
- 1M
- +13.24%
- 3M
- -21.21%
- 6M
- -20.59%
- YTD
- -17.50%
What is the market expecting?
Expected to make a loss, and analysts expect the price to rise The figures
AnalystsBuy8
Not ranked on value: this stock carries too few of the multiples to score against its sector.
Is the business delivering?
Sales are growing faster than at similar companies The figures
No reported quarters on file for this stock.
How does it compare?
Value rankingOXB.L is not ranked on value
What happens next?
Reports next on 25 Mar, in 159 days
Daily market updates
Get the brief
Get an interesting stock pick, updates on the AI sector, information on the biggest movers of the day, and more, in the Monday, Wednesday and Friday email.